anastrozole AI
Selected indexed studies
- Anastrozole. (Expert Opin Drug Saf, 2010) [PMID:20923259]
- Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3. (Ann Oncol, 2024) [PMID:38729566]
- Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. (Lancet, 2005) [PMID:15639680]
_Worker-drafted node — pending editorial review._
Connections
anastrozole AI is a side effect of
Sources
- Anastrozole. (2010) pubmed
- Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR(+)/HER2(-) Breast Cancer. (2020) pubmed
- New and Emerging Therapeutic Drugs for the Treatment of Pulmonary Arterial Hypertension: A Systematic Review. (2024) pubmed
- Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3. (2024) pubmed
- Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. (2005) pubmed
- Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer. (2020) pubmed
- Everolimus. (2018) pubmed
- Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. (2012) pubmed
- Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. (2024) pubmed
- Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature. (2016) pubmed